Sage Journals: Discover world-class research

Abstract

Background

Certain adipose tissue depots infer higher cardiometabolic risk than body mass index (BMI).

Purpose

To assess breast adipose tissue (BrAT) attenuation as a novel imaging biomarker for cardiometabolic risk.

Material and Methods

We studied 151 women (mean age = 56 ± 1 years) across the weight spectrum. BrAT attenuation, abdominal adipose tissue cross-sectional areas (CSA), and attenuation were quantified using non-contrast computed tomography (CT) scans. Cardiometabolic risk factors were assessed from medical records.

Results

BrAT attenuation was lower in obese women compared to lean women. BrAT attenuation was inversely associated with BMI, waist circumference, abdominal fat CSA, fasting glucose, and triglycerides (P ≤ 0.02), and positively associated with abdominal adipose tissue attenuation (P < 0.001). BrAT attenuation had a sensitivity of 90% but a specificity of only 35% in detecting the metabolic syndrome (area under the curve = 0.63).

Conclusion

BrAT attenuation is associated with cardiometabolic risk markers and could serve as an imaging biomarker for opportunistic risk assessment in patients undergoing CT examination of the chest.

Keywords

Breast adipose tissue computed tomography cardiometabolic risk metabolic syndrome opportunistic screening biomarker

Get full access to this article

View all access options for this article.

References

Bredella

Ghomi

Thomas

, et al. Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 tesla. J Comput Assist Tomogr 2010;34:372–376.

Gill CM, Azevedo DC, Oliveira AL, et al. Sex differences in pericardial adipose tissue assessed by PET/CT and association with cardiometabolic risk. Acta Radiol 2018;59:1203–9.

Lee

Pedley

Hoffmann

, et al. Visceral and intrahepatic fat are associated with cardiometabolic risk factors above other ectopic fat depots: the Framingham Heart Study. Am J Med 2018;131:684–692.e12.

Schorr

Dichtel

Gerweck

, et al. Sex differences in body composition and association with cardiometabolic risk. Biol Sex Differ 2018;9:28.

Cypess

Lehman

Williams

, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509–1517.

Bredella

Karastergiou

Bos

, et al. GH administration decreases subcutaneous abdominal adipocyte size in men with abdominal obesity. Growth Horm IGF Res 2017;35:17–20.

Cote

Nazare

Nadeau

, et al. Computed tomography-measured adipose tissue attenuation and area both predict adipocyte size and cardiometabolic risk in women. Adipocyte 2016;5:35–42.

Hemke

Takayesu

Hughes

, et al. Novel body composition predictors of outcome in patients with angiosarcoma of the breast: a preliminary study. J Comput Assist Tomogr 2020;44:605–609.

Ray

Mohllajee

van Dam

, et al. Breast size and risk of type 2 diabetes mellitus. CMAJ 2008;178:289–295.

10.

Schautz

Later

Heller

, et al. Associations between breast adipose tissue, body fat distribution and cardiometabolic risk in women: cross-sectional data and weight-loss intervention. Eur J Clin Nutr 2011;65:784–790.

11.

Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486–2497.

12.

Rosenquist

Massaro

Pedley

, et al. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab 2015;100:227–234.

13.

Veld

Vossen

De Amorim Bernstein

, et al. Adipose tissue and muscle attenuation as novel biomarkers predicting mortality in patients with extremity sarcomas. Eur Radiol 2016;26:4649–4655.

Breast adipose tissue attenuation as a novel imaging biomarker for cardiometabolic risk